Associazione Italiana Oncologia Medica - Carmine Pinto Stefania Gori - Doc Congress Srl

Associazione Italiana
     Oncologia Medica

Carmine Pinto Stefania Gori
Presidente Nazionale AIOM – Presidente Eletto AIOM

 Founded in Milan the 7 November 1973 by 20 Medical
   Oncologists

 AIOM is administered by a Board of 12 members: the President,
   President-elect, Secretary, Treasurer, eight councillors.

 With the aim of further promoting the objectives of the Society,
   19 Regional Sections were established in 1981, each of which
   brings together all of the members working in the Region. Each
   Section is managed by a Regional Board. Sections promote
   continuous medical education initiatives and scientific meetings.

 Main purpose of the Society is to bring together specialists in
   Medical Oncology with the aims of promoting progress in the
   clinical, experimental and social welfare fields;
 AIOM also encourage contacts between medical oncologists,
   general practitioners and specialists in other disciplines; establish
   scientific relationship with other similar national and international
   Societies; collaborate with local, regional and national
   institutional bodies.
 AIOM is also bringing together other important people dealing
   every day with malignant diseases such as nurses, study
   coordinators, advocates……having dedicated working groups for
   each category.

members

          N= 2316
          Oncologist (815 YOUNG)
          Nurse
          Study Coordinator
          Other

website

The collaboration with AIRTUM (Associazione italiana dei
                       registri tumori)
• Every year this collaboration leads to
 the Monography
“I NUMERI DEL CANCRO IN ITALIA”

Fonte: I numeri del cancro in Italia, AIOM-AIRTUM, 2017, www.aiom.it

          Primi cinque tumori più frequentemente diagnosticati

             Prime cinque cause di morte oncologica

National Data (incidence & mortality)
UNIVERSITY OF TORINO – DEPARTMENT OF ONCOLOGY

                                                                                 I:-1.7%
                                                                                 M: -2%

                                                • 41.800 new cases/yr
                                                  (N= 369.000)
                                                • First cause of cancer death
                                                  for every age group in
                                                  men: 14% deaths in young
                                                  (0-49aa), 30% in adults (50-             I: +3.1%
                                                  69 anni), 26% >70 aa                     M:+2%

Histology(incidence)-National Data

- Squamous carcinoma -2.6%
- Adenocarcinoma + 4.4%

                             - Squamous carcinoma +1.5%
                             - Adenocarcinoma + 8.4%

MEGLIO SMETTERE 2.0
Seconda edizione del progetto di prevenzione del tabagismo tra i giovanissimi

Festival of Prevention and
 Innovation in Oncology

     • The first itinerant festival of prevention
       and innovation in oncology: taking place in
       16 cities and started in December 2016

     • In collaboration with local Institutions with
       patients, advocates, testimonials in each
       city

     • The motorhome moves from one city to
       another

100,000 citizens involved in the first 10 cities,
85,000 brochures distributed

                       Reggio Emilia 16-18 dicembre 2016

                       Cremona 4 febbraio 2017

                       Brindisi   3-5 marzo 2017

                       Cosenza    10-12 marzo 2017

                       Palermo    15-17 marzo 2017

                       Napoli     20-22 marzo 2017

                       Frosinone 24-26 marzo 2017

                       Cagliari   29-31 marzo 2017

                       Firenze    3-5 aprile 2017

                       Arezzo     6-8 aprile 2017

Web App

   Arabic            Italian
   Chinese           Rumenian
   French            Russian
   English           Spanish

ESMO OPEN
   official
 Journal for
   AIOM

ESMO Designated Centres
           of Integrated Oncology & Palliative Care
Centri italiani (anno accreditamento)
Azienda Ospedaliero Universitaria di Cagliari, Oncologia Medica 1 - Cagliari (2010)
Istituto Neurotraumatologico Italiano (I.N.I.), Divisione Grottaferrata - Grottaferrata (2010)
Policlinico A Gemelli , Universita Cattolica del Sacro Cuore, Oncology Unit - Roma (2010)
S. Anna University Hospital, Clinical Oncology Unit - Ferrara (2010)
Fondazione Poliambulanza - U.O. Oncologia Medica - Brescia (2011)
Polo Oncologico Provinciale di Frosinone - Sora (2011)
University Hospital of Udine, Department of Oncology - Udine (2011)
Campus Bio Medico - Roma (2012)
Cancer Centre, Ospedale San Pietro Fatebenefratelli - Roma (2012)
Fondazione I.R.C.C.S. Policlinico San Matteo - Pavia (2012)
Istituto Oncologico Veneto - I.R.C.C.S. - Padova (2012)
Oncologia Medica Policlinico Universitario Tor Vergata (Rome)
 & San Raffaele Hospices (Rocca di Papa - Montecompatri) - Roma (2012)
U.O.C. Oncologia Medica, Azienda Ospedaliera Sant' Andrea, Sapienza Università Di Roma - Roma (2012)

Andamento della popolazione con cittadinanza
               straniera in Italia

ISTAT, 1 gennaio 2016

Progetto LINKAGE

            Information desk for Chinese patients

• A linguistic-cultural mediator
  for the management of Chinese
  patients

• National Registry specifically
  dedicated to Chinese pts

• AIOM (Associazione Italiana di oncologia Medica)
• GOIRC in Medical Oncolo (Gruppo Oncologico Italiano di Ricerca
    Clinica)
•   GONO (Gruppo Oncologico Nord Ovest)
•   ITMO (Italian Trials gy)
•   GOIM (Gruppo Oncologico Italia Meridionale)
•   GISCAD (Gr. Italiano Studio Carcinomi App. Digerente)
•   ISG (Italian Sarcoma Group, 1997) )
•   MITO (Multicenter Italian Trials in Ovarian Cancer)
•   IMI (Intergruppo Melanoma Italiano)
•   APRIC – CTPG (Clinical Trials Promoting Group)
•   GIM (Gruppo Italiano Mammella)
•   IGCCG (Italian Germ Cell Cancer Group)
•   ASTRO (Association for Traslation Research in Oncology)
•   Fondazione NIBIT (Network Italiano per la bioimmunoterapia dei
    tumori)
•   APRIC (Associazione per la promozione Ricerca Clinica)